BOULDER, Colo.--(BUSINESS WIRE)--Jan. 31, 2008--Array BioPharma
Inc. (Nasdaq: ARRY) will report financial results for the second
quarter of fiscal 2008 on Monday, February 4, 2008, and will hold a
conference call on Tuesday, February 5, 2008, at 9:00 a.m. Eastern
time to discuss these results. Robert E. Conway, Chief Executive
Officer, and Michael Carruthers, Chief Financial Officer, will lead
Conference Call Information
Date: Tuesday, February 5, 2008
Time: 9:00 a.m. Eastern time
Pass Code: 1104499
Web Cast: www.arraybiopharma.com
A replay of the call will be available as a webcast on
www.arraybiopharma.com and by phone for one week by dialing toll-free
(888) 203-1112 or (719) 457-0820. The access code is 1104499.
Array BioPharma Inc. is a biopharmaceutical company focused on the
discovery, development and commercialization of targeted small
molecule drugs to treat life threatening and debilitating diseases.
Our proprietary drug development pipeline is focused on the treatment
of cancer and inflammatory diseases and includes clinical candidates
that are designed to regulate therapeutically important targets. In
addition, leading pharmaceutical and biotechnology companies access
Array's drug discovery technologies and expertise through
collaborations to design, create, optimize and evaluate drug
candidates across a broad range of therapeutic areas. For more
information on Array, please go to www.arraybiopharma.com.
CONTACT: Array BioPharma Inc.
Tricia Haugeto, 303-386-1193
SOURCE: Array BioPharma Inc.